ArticleCancer biology & therapy2011

Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic marker.

Rajan Dewar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.